Recent Advances in Lipid Nanoparticles: Nucleic Acid Therapeutics and Targeting Strategies

Area of Science:

• Biotechnology
• Nanomedicine
• Drug Delivery Systems

Background:

• Lipid nanoparticles (LNPs) are emerging as a key platform in drug delivery.
• They are particularly effective for administering fragile nucleic acid therapeutics like messenger RNA (mRNA) and small interfering RNA (siRNA).
• The demand for noninvasive, targeted therapies necessitates advancements in LNP technology.

Purpose of the Study:

• To provide a comprehensive overview of lipid nanoparticles (LNPs).
• To discuss their fundamental composition, development, and application in nucleic acid delivery.
• To highlight innovative synthesis techniques and targeting strategies for LNPs.

Main Methods:

• Review of current literature on LNP composition and fabrication.
• Analysis of LNP applications in delivering nucleic acid-based therapeutics.
• Discussion of advancements in ionizable lipid synthesis and targeting mechanisms.

Main Results:

• LNPs demonstrate significant potential for targeted delivery of fragile biomolecules.
• Current research addresses challenges in tissue selectivity, payload capacity, and immunogenicity.
• Innovative ionizable lipids and targeting strategies are expanding LNP capabilities.

Conclusions:

• Lipid nanoparticles (LNPs) represent a revolutionary advancement in drug delivery systems.
• Their versatility and efficacy position them to transform the administration of nucleic acid therapeutics.
• Further development promises enhanced precision medicine and reduced adverse effects.